Artículo de Revisión 21.- Stickel F. Natural history of ALD: role of 28 environmental and genetic factors. En: EASL. The International Liver Congress 2012. EASL Post Graduate Curse. Alcoholic Liver Disease. Barcelona; 2012. p. 32-5. 22.- Sato N, Lindros KO, Baraona E, Ikejima K, Mezey E, Jarvelainen HA, et al. Sex difference in alcohol-related organ injury. Alcohol Clin Exp Res 2001; 25: 40S-45S. 23.- Frezza M, Di Padova C, Pozzato G, Terpin M, Barona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Eng J Med 1990; 322: 95-9. 24.- Stewart SH. Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gammaglutamyltransferase elevation. Arch Intern Med 2002; 162: 2236-9. 25.- Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res 2001; 25: 1181-7. 26.- Mendenhall C, Roselle GA, Gartside P, Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two veterans administration cooperative studies. Alcohol Clin Exp Res 1995; 19: 635-41. 27.- Mezey E. Dietary fat and alcoholic liver disease. Hepatology 1998; 28: 901-5. 28.- Leevy CM, Moroianu SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis 2005; 9: 67-81. 29.- Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25: 108-11. 30.- Iturriaga H, Bunout B, Hirsch S, Ugarte G. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 1988; 47: 235-8. 31.- Bunout D, Petermann M, Bravo M, Kelly M, Hirsch S, Ugarte G, et al. Glucose turnover rate and peripheral insulin sensivity in alcoholic patients without liver damage. Ann Nutr Metab 1989; 33: 31-8. 32.- Xu J, Lai KK, Verlilnsky A, Lugea A, French SW, Cooper MP, et al. Synergistic Enfe rmedad hep ática po r alcohol - R. Lazarte C. et al. steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol 2011; 55: 673-82. 33.- Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ, Hollinger FB, et al. The relationship of acute transfusionassociated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 2001; 134: 120-4. 34.- Holman G, Alhmoud A, Mougey A, Shuhong G, Al-Sadi R, Gannavarapu B, et al. Mechanism of alcoholic hepatitis: relationship between leaky gut, endotoxemia, and pro-inflammatory cytokines. Gastroenterology 2014; 146 (5), Suppl 1: S11. 35.- Parola M, Robino G. Oxidative stressrelated molecules and liver fibrosis. J Hepatol 2001; 35: 297-306. 36.- Yuan GJ, Zhou XR, Gong ZJ, Zhang P, Sun XM, Zheng SH. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World J Gastroent 2006; 12: 2375-81. 37.- Niemela O, Parkkila S, Yla-Herttuala, Hasted C, Witztum JL, Lanca A, et al. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994; 70: 537-46. 38.- Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A. Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells. Alcohol Clin Exp Res 2007; 31: 846-54. 39.- Nanji AA, Zakim D. Alcoholic liver disease. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease. Ed 3. Philadelphia: Saunders 1996: 891-961. 40.- Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, et al. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 1997; 26: 1538-45. 41.- Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-5. 42.- Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010; 42: 21-3. 43.- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76. 44.- Decaens T. Hepatocellular carcinoma: is it different in patients with alcoholic liver disease? En: EASL. The International Liver Congress 2012. EASL Post Graduate Curse. Alcoholic Liver Disease. Barcelona; 2012. p. 131-5. 45.- Lucey MR. Management of alcoholic liver disease. Clin Liver Dis 2009; 13: 267-75. 46.- Ewing JA. “Detecting Alcoholism: The CAGE Questionaire” JAMA 252: 1905-1907, 1984. Steinweg DL and Worth H; “Alcoholism: The Keys to the CAGE” Am J Med 94: 520-523 1993 May. 47.- Levine J. The relative value of consultation, questionnaires and laboratory investigation in the identification of excessive alcohol consumption. Alcohol Alcohol 1990; 25: 539-53. 48.- U.S. Department of Health and Human Services, National Institute of Health, National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician’s guide. NIH Publications 07-3769; 2008 update. Disponible en: www.niaaa.nih.gov/guide. Consultado el 30 de julio de 2015. 49.- Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-69. 50.- Mueller S. Noninvasive tools in the diagnosis of ALD. En: EASL. The International Liver Congress 2012. EASL Post Graduate Curse. Alcoholic Liver Disease. Barcelona; 2012. p. 59-75. 51.- Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-9. 52.- Lazarte R, Pavez C, Poniachik J. Enfermedad hepática por alcohol. En: Tagle M y Bussalleu A, editores, Avances en Hepatología 2012. Gastroenterol. latinoam 2016; Vol 27, Nº 1: 18-30
gastro-1-2016
To see the actual publication please follow the link above